PTCT Earnings

Quarterly EPS
$-1.39
Q3 2024
$-0.85
Q4 2024
$11.09
Q1 2025
$-0.83
Q2 2025
$0.20
Q3 2025
$-1.62
Q4 2025
$-0.03
Q1 2026
$1.01
Q2 2026
Latest Revenue360.5M
Latest Net Income83.5M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026$1.01360.5M83.5M+101.5%+221.7%
Q1 2026-$0.03272.6M-2809000-76.8%-100.3%
Q4 2025-$1.62164.7M-134965000-22.7%-90.6%
Q3 2025$0.20211.0M15.9M+7.2%+114.4%
Q2 2025-$0.83178.9M-64849000-4.2%+35.7%
Q1 2025$11.091.2B866.6M+459.7%+1,024.2%
Q4 2024-$0.85213.2M-65886000-30.6%+58.7%
Q3 2024-$1.39196.8M-106654000+0.1%+21.0%
Q2 2024-$1.29186.7M-99179000
Q1 2024-$1.20210.1M-91576000
Q4 2023-$2.06307.1M-155792000
Q3 2023-$1.76196.6M-132970000
PTC Therapeutics (PTCT) — Earnings